Prioritizing the patient: optimizing therapy in rheumatoid arthritis. Results of a patient questionnaire in northern Germany

por Wollenhaupt, Jürgen, Ehlebracht-Koenig, Inge, Groenewegen, André, Fricke, Dieter
Publicado 2013

Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteria

por Iking-Konert, Christof, Aringer, Martin, Wollenhaupt, Jürgen, Mosch, Thomas, Tuerk, Stefan, Feist, Eugen, Burmester, Gerd R
Publicado 2011

Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studi...

por Fleischmann, Roy, Wollenhaupt, Jürgen, Takiya, Liza, Maniccia, Anna, Kwok, Kenneth, Wang, Lisy, van Vollenhoven, Ronald F
Publicado 2017

Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Ab...

por Smolen, Josef S., Wollenhaupt, Jürgen, Gomez-Reino, Juan J., Grassi, Walter, Gaillez, Corine, Poncet, Coralie, Le Bars, Manuela, Westhovens, Rene
Publicado 2015

Assessment of radiographic progression in patients with rheumatoid arthritis treated with tofacitinib in long-term studies

por van der Heijde, Désirée, Landewé, Robert B M, Wollenhaupt, Jürgen, Strengholt, Sander, Terry, Ketti, Kwok, Kenneth, Wang, Lisy, Cohen, Stanley
Publicado 2020

Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis

por Kaine, Jeffrey, Tesser, John, Takiya, Liza, DeMasi, Ryan, Wang, Lisy, Snyder, Mark, Soma, Koshika, Fan, Haiyun, Bandi, Vara, Wollenhaupt, Jürgen
Publicado 2020

Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity

por Pope, Janet, Bingham, Clifton O., Fleischmann, Roy M., Dougados, Maxime, Massarotti, Elena M., Wollenhaupt, Jürgen, Duncan, Benjamin, Coteur, Geoffroy, Weinblatt, Michael E.
Publicado 2015

Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, rand...

por Smolen, Josef S, Kay, Jonathan, Doyle, Mittie, Landewé, Robert, Matteson, Eric L, Gaylis, Norman, Wollenhaupt, Jürgen, Murphy, Frederick T, Xu, Stephen, Zhou, Yiying, Hsia, Elizabeth C
Publicado 2015

Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib

por Dikranian, Ara, Gold, David, Bessette, Louis, Nash, Peter, Azevedo, Valderilio F., Wang, Lisy, Woolcott, John, Shapiro, Andrea B., Szumski, Annette, Fleishaker, Dona, Wollenhaupt, Jürgen
Publicado 2021

Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, doub...

por Smolen, Josef S, Kay, Jonathan, Landewé, Robert B M, Matteson, Eric L, Gaylis, Norman, Wollenhaupt, Jurgen, Murphy, Frederick T, Zhou, Yiying, Hsia, Elizabeth C, Doyle, Mittie K
Publicado 2012

Long‐Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials

por Mease, Philip J., Gladman, Dafna D., Gomez‐Reino, Juan J., Hall, Stephen, Kavanaugh, Arthur, Lespessailles, Eric, Schett, Georg, Paris, Maria, Delev, Nikolay, Teng, Lichen, Wollenhaupt, Jürgen
Publicado 2020

Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study

por Combe, Bernard, Dasgupta, Bhaskar, Louw, Ingrid, Pal, Sarvajeet, Wollenhaupt, Jürgen, Zerbini, Cristiano A F, Beaulieu, Andre D, Schulze-Koops, Hendrik, Durez, Patrick, Yao, Ruji, Vastesaeger, Nathan, Weng, Haoling H
Publicado 2014

Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study

por Wollenhaupt, Jürgen, Lee, Eun-Bong, Curtis, Jeffrey R., Silverfield, Joel, Terry, Ketti, Soma, Koshika, Mojcik, Chris, DeMasi, Ryan, Strengholt, Sander, Kwok, Kenneth, Lazariciu, Irina, Wang, Lisy, Cohen, Stanley
Publicado 2019

Mustercurriculum der Deutschen Gesellschaft für Rheumatologie für die Weiterbildung im Fachgebiet Innere Medizin und Rheumatologie

por Pfeil, Alexander, Krusche, Martin, Vossen, Diana, Berliner, Michael N., Keyßer, Gernot, Krause, Andreas, Lorenz, Hanns-Martin, Manger, Bernhard, Schuch, Florian, Specker, Christof, Wollenhaupt, Jürgen, Baraliakos, Xenofon, Fleck, Martin, Proft, Fabian
Publicado 2021

Model curriculum of the German society for Rheumatology for advanced training in the discipline internal medicine and rheumatology. English version

por Pfeil, Alexander, Krusche, Martin, Vossen, Diana, Berliner, Michael N., Keyßer, Gernot, Krause, Andreas, Lorenz, Hanns-Martin, Manger, Bernhard, Schuch, Florian, Specker, Christof, Wollenhaupt, Jürgen, Baraliakos, Xenofon, Fleck, Martin, Proft, Fabian
Publicado 2021

Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis

por Westhovens, Rene, Robles, Manuel, Ximenes, Antonio Carlos, Wollenhaupt, Jurgen, Durez, Patrick, Gomez-Reino, Juan, Grassi, Walter, Haraoui, Boulos, Shergy, William, Park, Sung-Hwan, Genant, Harry, Peterfy, Charles, Becker, Jean-Claude, Murthy, Bindu
Publicado 2015

Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1–3 studies

por Gladman, Dafna D, Kavanaugh, Arthur, Gómez-Reino, Juan J, Wollenhaupt, Jürgen, Cutolo, Maurizio, Schett, Georg, Lespessailles, Eric, Guerette, Benoit, Delev, Nikolay, Teng, Lichen, Edwards, Christopher J, Birbara, Charles A, Mease, Philip J
Publicado 2018

Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor

por Kavanaugh, Arthur, Mease, Philip J, Gomez-Reino, Juan J, Adebajo, Adewale O, Wollenhaupt, Jürgen, Gladman, Dafna D, Lespessailles, Eric, Hall, Stephen, Hochfeld, Marla, Hu, ChiaChi, Hough, Douglas, Stevens, Randall M, Schett, Georg
Publicado 2014

Rheumatologische Weiterbildungsstellen in Deutschland

por Pfeil, Alexander, Krusche, Martin, Proft, Fabian, Vossen, Diana, Braun, Jürgen, Baraliakos, Xenofon, Berliner, Michael N., Keyßer, Gernot, Krause, Andreas, Lorenz, Hanns-Martin, Manger, Bernhard, Schuch, Florian, Specker, Christof, Wollenhaupt, Jürgen, Voormann, Anna, Fleck, Martin
Publicado 2022

4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis

por van der Heijde, Désirée, Deodhar, Atul, FitzGerald, Oliver, Fleischmann, Roy, Gladman, Dafna, Gottlieb, Alice B, Hoepken, Bengt, Bauer, Lars, Irvin-Sellers, Oscar, Khraishi, Majed, Peterson, Luke, Turkiewicz, Anthony, Wollenhaupt, Jürgen, Mease, Philip J
Publicado 2018